New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 14, 2012
10:00 EDTCYTXCytori Therapeutics falls 16.9%
Cytori Therapeutics is down 16.9%, or 56c, to $2.76
News For CYTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
08:13 EDTCYTXCytori Therapeutics sees FY15 product revenue $5M-$8M
Subscribe for More Information
08:11 EDTCYTXCytori Therapeutics reports prelim Q4 revenue $2.5M, two estimates $2.46M
Subscribe for More Information
February 26, 2015
08:02 EDTCYTXCytori Therapeutics says receives FDA approval to expand Scleroderma trial
Cytori Therapeutics announced that it received approval from FDA to expand the number of Scleroderma clinical trial sites from 12 to 20 centers in the United States. The STAR study is an 80 patient pivotal clinical trial approved by FDA in January to study the effects of Cytori’s lead drug ECCS-50 for treatment of patients with hand manifestations of Scleroderma.
February 24, 2015
08:17 EDTCYTXCytori Therapeutics receives positive European opinion on orphan drug status
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use